SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-038936
Filing Date
2010-02-24
Accepted
2010-02-24 16:36:02
Documents
9
Period of Report
2010-02-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 35146
2 EXECUTIVE EMPLOYMENT AGREEMENT dex101.htm EX-10.1 129154
3 STOCK OPTION AGREEMENT dex102.htm EX-10.2 37634
4 SEPARATION OF EMPLOYMENT AND CONSULTING AGREEMENT dex103.htm EX-10.3 131559
5 PRESS RELEASE RE: MR. ADAMS' APPOINTMENT dex991.htm EX-99.1 15913
6 PRESS RELEASE RE: NASDAQ 5635(C)(4) AWARDS dex992.htm EX-99.2 9667
7 GRAPHIC g13962ex99_1pg001.jpg GRAPHIC 16872
8 GRAPHIC g13962ex99_2pg001b.jpg GRAPHIC 3421
9 GRAPHIC g13962g29e26.jpg GRAPHIC 1025
  Complete submission text file 0001193125-10-038936.txt   390541
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31577 | Film No.: 10630180
SIC: 2834 Pharmaceutical Preparations